Testosterone Replacement Therapy Market Introduction and Overview
According to SPER Market Research, the Global Testosterone Replacement Therapy Market is estimated to reach USD 3.03 billion by 2033 with a CAGR of 4.41%.
The report includes an in-depth analysis of the Global Testosterone Replacement Therapy Market, including market size and trends, product mix, applications, and supplier analysis. A medical procedure called testosterone replacement therapy (TRT) is used to treat people with low testosterone levels, especially men. The primary male sex hormone, testosterone, is essential for many body processes, including the growth of secondary sexual traits, the maintenance of muscle mass, bone density, and energy levels. People who have lower testosterone levels as a result of ageing, illnesses, or other causes may notice symptoms like lethargy, decreased libido, mood swings, and impaired cognitive performance. In order to relieve these symptoms and possibly enhance general wellbeing, testosterone replacement therapy attempts to return testosterone levels to normal ranges.
- January 2023; SEZABY (phenobarbital sodium) is introduced by Sun Pharmaceutical Industries Ltd. to treat newborn seizures in the United States. SEZABY is a phenobarbital sodium powder for injection that is free of propylene glycol and benzyl alcohol.
- May 2023; Enzene Biosciences and Lupin Limited have formed a strategic partnership to introduce Cetuximab, the first biosimilar for Cetuximab, in India. This partnership represents a major turning point in the development of novel treatments and the expansion of therapeutic choices for head and neck cancer patients.
Market Opportunities and Challenges
Opportunities: The ageing population worldwide is one of the main factors propelling the market for testosterone replacement therapy. People's natural testosterone levels tend to decline with age. A decrease in testosterone levels can cause a number of symptoms, such as depression, tiredness, decreased muscular mass, and sexual dysfunction. The growing knowledge and understanding of testosterone deprivation and its effects on general health is another important motivator. The possible advantages of testosterone replacement therapy are coming to the attention of both patients and medical professionals. As awareness increases, more people are consulting doctors and looking into hormone imbalance treatments.
Challenge : The market for testosterone replacement therapy is significantly constrained by worries about possible adverse effects and safety hazards. Although testosterone treatment has many advantages, there are drawbacks as well. Acne, fluid retention, mood fluctuations, and an elevated risk of cardiovascular problems are common adverse effects. Due to the link between testosterone therapy and some side effects, like heart issues, patients and healthcare professionals are being extra cautious. Because some people may be discouraged from pursuing testosterone replacement therapy due to the perceived hazards, the market's potential growth may be restricted.
Market Competitive Landscape
In order to create cutting-edge TRT products and treatment alternatives, businesses are making significant investments in research and development. To improve therapy efficacy, patient compliance, and convenience, this entails investigating novel formulations, delivery methods, and technological advancements. To substantiate the safety and effectiveness of their TRT treatments, a number of prominent companies are undertaking clinical trials. These studies support their efforts to obtain regulatory clearances and validate the therapeutic effects of their products. The major players in the market are Abbvie Inc., Acrux Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International Gmbh, Cipla Inc., Glaxosmithkline Plc., Hikma Pharmaceuticals Plc, Johnsons & Johnsons Services Inc., Marius Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Indication, By Product Type, By Drug Active Ingredient, By End-Users
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Abbvie Inc., Acrux Ltd., Bausch Health Companies Inc., Boehringer Ingelheim International Gmbh, Cipla Inc., Glaxosmithkline Plc., Hikma Pharmaceuticals Plc, Johnsons & Johnsons Services Inc., Marius Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Others. |
COVID-19 Impact on Global Testosterone Replacement Therapy Market
Since hormone withdrawal could accelerate the spread of Covid-19 in the body and older women are more susceptible to illness, the lockdown has had a severe negative impact on the global economy. As a result, countries around the world have prioritised primary healthcare and have ignored all other forms of medical care, which has caused a pause in the market. Hospital infrastructure shortages have also made the pandemic worse. Despite these challenges, major players in the market continue to make every attempt to maintain competition in the market, and the market is anticipated to rebound now that the pandemic has passed.
Key Target Audience:
- Physicians and Urologists
- Men's Health Clinics and Wellness Centers
- Fitness Enthusiasts and Bodybuilders
- Partner Support Groups
Our in-depth analysis of the Testosterone Replacement Therapy Market includes the following segments:
|
By Indication: |
Hypogonadism
Autoimmune Conditions
Genetic Disorders
Sex Organ Surgeries
|
|
By Product Type: |
Oral
Parenteral
Implants
Gel/Creams
Patches
Buccal Adhesive
|
|
By Drug Active Ingredient: |
Testosterone Cypionate
Testosterone
Testosterone Enanthate
Methyltestosterone
|
|
By End-Users: |
Hospitals
Clinics
|
Key Topics Covered in the Report:- Global Testosterone Replacement Therapy Market Size (FY’2024-FY’2033)
- Overview of Global Testosterone Replacement Therapy Market
- Segmentation of Global Testosterone Replacement Therapy Market By Indication (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries)
- Segmentation of Global Testosterone Replacement Therapy Market By Product Type (Oral, Parenteral, Implants, Gel/Creams, Patches, Buccal Adhesive)
- Segmentation of Global Testosterone Replacement Therapy Market By Drug Active Ingredient (Testosterone Cypionate, Testosterone, Testosterone Enanthate, Methyltestosterone)
- Segmentation of Global Testosterone Replacement Therapy Market By End-Users (Hospitals and Clinics)
- Statistical Snap of Global Testosterone Replacement Therapy Market
- Expansion Analysis of Global Testosterone Replacement Therapy Market
- Problems and Obstacles in Global Testosterone Replacement Therapy Market
- Competitive Landscape in the Global Testosterone Replacement Therapy Market
- Impact of COVID-19 and Demonetization on Global Testosterone Replacement Therapy Market
- Details on Current Investment in Global Testosterone Replacement Therapy Market
- Competitive Analysis of Global Testosterone Replacement Therapy Market
- Prominent Players in the Global Testosterone Replacement Therapy Market
- SWOT Analysis of Global Testosterone Replacement Therapy Market
- Global Testosterone Replacement Therapy Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report
1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPER’s internal database
2.1.4.Premium insight from KOL’s
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
4.2.COVID-19 Impacts of the Global Testosterone Replacement Therapy Market.
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTER’s Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Testosterone Replacement Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Testosterone Replacement Therapy Market
7.Global Testosterone Replacement Therapy Market, By Indication (USD Million) 2020-2033
7.1.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By Indication, 2020-2026
7.2.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By Indication, 2027-2033
7.3.Hypogonadism
7.4.Autoimmune Conditions
7.5.Genetic Disorders
7.6.Sex Organ Surgeries
8.Global Testosterone Replacement Therapy Market, By Product Type (USD Million) 2020-2033
8.1.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By Product Type, 2020-2026
8.2.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By Product Type, 2027-2033
8.3.Oral
8.4.Parenteral
8.5.Implants
8.6.Gel/Creams
8.7.Patches
8.8.Buccal Adhesive
9.Global Testosterone Replacement Therapy Market, By Drug Active Ingredient (USD Million) 2020-2033
9.1.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By Drug Active Ingredient, 2020-2026
9.2.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By Drug Active Ingredient, 2027-2033
9.3.Testosterone Cypionate
9.4.Testosterone
9.5.Testosterone Enanthate
9.6.Methyltestosterone
10.Global Testosterone Replacement Therapy Market, By End-Users (USD Million) 2020-2033
10.1.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By End-Users, 2020-2026
10.2.Global Testosterone Replacement Therapy Market Size, Share and Forecast, By End-Users, 2027-2033
10.3.Hospitals
10.4.Clinics
11.Global Testosterone Replacement Therapy Market Forecast, 2020-2033 (USD Million)
11.1.Global Testosterone Replacement Therapy Market Size and Market Share
12.Global Testosterone Replacement Therapy Market, By Region, 2020-2033 (USD Million)
12.1.Global Testosterone Replacement Therapy Market Size and Market Share By Region (2020-2026)
12.2.Global Testosterone Replacement Therapy Market Size and Market Share By Region (2027-2033)
12.3.Asia-Pacific
12.3.1.Australia
12.3.2.China
12.3.3.India
12.3.4.Japan
12.3.5.South Korea
12.3.6.Rest of Asia-Pacific
12.4.Europe
12.4.1.France
12.4.2.Germany
12.4.3.Italy
12.4.4.Spain
12.4.5.United Kingdom
12.4.6.Rest of Europe
12.5.Middle East and Africa
12.5.1.Kingdom of Saudi Arabia
12.5.2.United Arab Emirates
12.5.3.Qatar
12.5.4.South Africa
12.5.5.Egypt
12.5.6.Morocco
12.5.7.Nigeria
12.5.8.Rest of Middle-East and Africa
12.6.North America
12.6.1.Canada
12.6.2.Mexico
12.6.3.United States
12.7.Latin America
12.7.1.Argentina
12.7.2.Brazil
12.7.3.Rest of Latin America
13.Company Profile
13.1.ABBVIE INC.
13.1.1.Company details
13.1.2.Financial outlook
13.1.3.Product summary
13.1.4.Recent developments
13.2.ACRUX LTD.
13.2.1.Company details
13.2.2.Financial outlook
13.2.3.Product summary
13.2.4.Recent developments
13.3.BAUSCH HEALTH COMPANIES INC.
13.3.1.Company details
13.3.2.Financial outlook
13.3.3.Product summary
13.3.4.Recent developments
13.4.BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.4.1.Company details
13.4.2.Financial outlook
13.4.3.Product summary
13.4.4.Recent developments
13.5.CIPLA INC.
13.5.1.Company details
13.5.2.Financial outlook
13.5.3.Product summary
13.5.4.Recent developments
13.6.GLAXOSMITHKLINE PLC.
13.6.1.Company details
13.6.2.Financial outlook
13.6.3.Product summary
13.6.4.Recent developments
13.7.HIKMA PHARMACEUTICALS PLC
13.7.1.Company details
13.7.2.Financial outlook
13.7.3.Product summary
13.7.4.Recent developments
13.8. JOHNSONS & JOHNSONS SERVICES INC
13.8.1.Company details
13.8.2.Financial outlook
13.8.3.Product summary
13.8.4.Recent developments
13.9.MARIUS PHARMACEUTICALS
13.9.1.Company details
13.9.2.Financial outlook
13.9.3.Product summary
13.9.4.Recent developments
13.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.10.1.Company details
13.10.2.Financial outlook
13.10.3.Product summary
13.10.4.Recent developments
13.11.Others
14.Conclusion
15.List of Abbreviations
16.Reference Links